Pricing for childhood vaccines are referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

Merck Sharp & Dohme Corp has been awarded a Texas state contract (HHSTX-5-0000380404) for the procurement of childhood vaccines, with pricing referenced to the Centers for Disease Control and Prevention (CDC) Federal Contract Number 75D30125D00195. The contract encompasses multiple vaccine types, including Botulinum toxin, Haemophilus influenzae b with diphtheria and tetanus and acellular pertussis, Smallpox vaccine, Pneumococcal vaccine, and Pertussis vaccine, as categorized by their respective United Nations Standard Products and Services Code (UNSPSC) classifications.

The contract, dated July 25, 2025, falls under the National Institute of Governmental Purchasing (NIGP) code 26980 for Serums, Toxoids, and Vaccines. While specific contract value details are not provided, the award indicates a state-level procurement focused on childhood immunization products. The contract appears to leverage existing federal pricing structures from the CDC, suggesting a strategic approach to vaccine acquisition that potentially provides cost-effective solutions for the state of Texas's public health immunization programs.